Catalyst Crew Technologies Announces Strategic Shift to AI Healthcare and Planned Rebranding as LataMed AI Corp.

Catalyst Crew Technologies Corp. has announced a significant strategic shift, transitioning from its prior business focus to become a development-stage artificial intelligence-enabled healthcare technology company. The company disclosed this material change in a Form 8-K filed with the U.S. Securities and Exchange Commission, which is available for review on the SEC's EDGAR database at https://www.sec.gov/Archives/edgar/data/1840439/000119312526068375/d95198d8k.htm. This strategic pivot represents a fundamental reorientation of the company's operations and market approach, with initial focus directed toward Latin America and other emerging markets where healthcare technology infrastructure may be developing.

The company's anticipated areas of focus include the development of AI-driven healthcare software platforms, telehealth and remote patient monitoring technologies, clinical data analytics and interoperability systems, healthcare workflow and administrative automation solutions, and strategic acquisitions and partnerships within the healthcare technology sector. Catalyst Crew Technologies remains in the development stage of this strategic transition and is actively implementing its new plan of operations, though there can be no assurance that the company will successfully implement its new business plan, secure financing, complete acquisitions, enter into definitive agreements, or generate revenues from these initiatives.

In connection with its revised strategic direction, the company intends to change its corporate name to LataMed AI Corp. The proposed name change is expected to be effected through the filing of Articles of Amendment with the State of Nevada and is subject to required corporate approvals. Additionally, the company intends to submit a Company Related Action Notification Form and supporting documentation to the Financial Industry Regulatory Authority, requesting review and processing of both the corporate name change and a corresponding ticker symbol change. Neither the corporate name change for marketplace purposes nor any ticker symbol change will become effective until FINRA has completed its review and announces the effective date of the corporate action.

The company intends to continue meeting its reporting obligations under the Securities Exchange Act of 1934 and will provide updated disclosures through filings with the SEC and through OTC Markets Group as applicable. Catalyst Crew Technologies is in the process of developing a new corporate website that will reflect its updated business direction and branding and expects to provide additional updates as they become available. This announcement represents a significant corporate transformation that aligns with growing global interest in AI applications within healthcare, particularly in regions where digital health infrastructure may present both challenges and opportunities for innovation.